Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy

Author： Waterhouse Dawn N   Bally Marcel B  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.1, Iss.3, 2006-10, pp. : 359-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanotechnology for antiangiogenic cancer therapy

By Kobayashi Hanako   Lin P Charles  

Nanomedicine, Vol. 1, Iss. 1, 2006-06 ,pp. : 17-22

Future Medicine

Access to resources Recommend Favorite

Antiangiogenic Therapy and Ovarian Cancer

By  

Current Women's Health Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 33-44

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic therapy in breast cancer

By Atiqur Rahman M.   Toi M.  

Biomedicine and Pharmacotherapy, Vol. 57, Iss. 10, 2003-12 ,pp. : 463-470

Elsevier

Access to resources Recommend Favorite

Antiangiogenic Agents Combined with Chemotherapy in the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Overall and Histology Subgroup-Specific Meta-Analysis

By  

Oncology Research and Treatment, Vol. 37, Iss. 12, 2014-11 ,pp. : 710-718

Karger

Access to resources Recommend Favorite

Antiangiogenic Metronomic Chemotherapy

By  

Oncology Research and Treatment, Vol. 31, Iss. 4, 2008-03 ,pp. : 161-162

Karger

Access to resources Recommend Favorite